222 related articles for article (PubMed ID: 37736588)
21. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
Rodriguez-Smith JJ; Verweyen EL; Clay GM; Esteban YM; de Loizaga SR; Baker EJ; Do T; Dhakal S; Lang SM; Grom AA; Grier D; Schulert GS
Lancet Rheumatol; 2021 Aug; 3(8):e574-e584. PubMed ID: 34124694
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis.
Zhang H; Zheng Q; Li F
J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.
Dhaliwal M; Tyagi R; Malhotra P; Barman P; Loganathan SK; Sharma J; Sharma K; Mondal S; Rawat A; Singh S
Front Pediatr; 2022; 10():790273. PubMed ID: 35601440
[TBL] [Abstract][Full Text] [Related]
24. Erythema and Induration of Bacillus Calmette-Guérin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report.
Tsuboya N; Makino H; Mitani Y; Ito M; Ohya K; Morimoto M; Hanaki R; Yodoya N; Ohashi H; Sawada H; Sugiyama K; Hirayama M
Front Pediatr; 2022; 10():849473. PubMed ID: 35359902
[TBL] [Abstract][Full Text] [Related]
25. Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review.
Kiss A; Ryan PM; Mondal T
Prog Pediatr Cardiol; 2021 Dec; 63():101381. PubMed ID: 33850412
[TBL] [Abstract][Full Text] [Related]
26. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series.
Shikhare AR; Iqbal RM; Tariq R; Turner DR; Gebara BM; Freij BJ
Glob Pediatr Health; 2021; 8():2333794X21996613. PubMed ID: 33748343
[TBL] [Abstract][Full Text] [Related]
27. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
28. A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.
Shahbaz FF; Martins RS; Umair A; Ukrani RD; Jabeen K; Sohail MR; Khan E
Clin Med Insights Pediatr; 2022; 16():11795565221075319. PubMed ID: 35197719
[TBL] [Abstract][Full Text] [Related]
29. VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes.
Ricke DO; Smith N
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541678
[TBL] [Abstract][Full Text] [Related]
30. Kawasaki Disease and COVID-19.
Gkoutzourelas A; Bogdanos DP; Sakkas LI
Mediterr J Rheumatol; 2020 Sep; 31(Suppl 2):268-274. PubMed ID: 33196004
[TBL] [Abstract][Full Text] [Related]
31. Kawasaki Disease Shock Syndrome in the Eastern Region of Saudi Arabia: Case Series.
Busaleh F; AlKadhem SM; Albarrak A; Almubarak AA; Aldandan MM; Almajed JM; Alabdullah MA; Almulaifi LF
Cureus; 2021 May; 13(5):e14961. PubMed ID: 34123658
[TBL] [Abstract][Full Text] [Related]
32. Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.
Chang L; Yang HW; Lin TY; Yang KD
Front Pediatr; 2021; 9():697632. PubMed ID: 34350146
[TBL] [Abstract][Full Text] [Related]
33. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study.
Kostik MM; Bregel LV; Avrusin IS; Dondurei EA; Matyunova AE; Efremova OS; Isupova EA; Kornishina TL; Masalova VV; Snegireva LS; Shprakh VV; Kozlov YA; Kalashnikova OV; Chasnyk VG
Front Pediatr; 2021; 9():787353. PubMed ID: 34858909
[No Abstract] [Full Text] [Related]
35. Kawasaki disease shock syndrome: A report of two cases and literature review.
Zhang Q; Liao Y; Du J
Pediatr Investig; 2019 Jun; 3(2):81-85. PubMed ID: 32851296
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
[TBL] [Abstract][Full Text] [Related]
37. Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease.
Netea SA; Biesbroek G; van Stijn D; Ijspeert H; van der Made CI; Jansen MH; Geissler J; van den Berg JMM; van der Kuip M; Gruppen MP; Schonenberg-Meinema D; Kapitein B; van Furth AMMT; Nagelkerke SQ; Pajkrt D; Plötz FB; den Boer MEJL; Landman GW; van Houten MA; Goetschalckx I; ; Toonen EJM; van de Veerdonk FL; Kuipers IM; Dik WA; Kuijpers TW
EBioMedicine; 2023 Sep; 95():104736. PubMed ID: 37524002
[TBL] [Abstract][Full Text] [Related]
38. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.
Bordea MA; Costache C; Grama A; Florian AI; Lupan I; Samasca G; Deleanu D; Makovicky P; Makovicky P; Rimarova K
Physiol Res; 2022 Mar; 71(1):17-27. PubMed ID: 35043641
[TBL] [Abstract][Full Text] [Related]
39. Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children.
Lin J; Harahsheh AS; Raghuveer G; Jain S; Choueiter NF; Garrido-Garcia LM; Dahdah N; Portman MA; Misra N; Khoury M; Fabi M; Elias MD; Dionne A; Lee S; Tierney ESS; Ballweg JA; Manlhiot C; McCrindle BW
Can J Cardiol; 2023 Jun; 39(6):793-802. PubMed ID: 36626979
[TBL] [Abstract][Full Text] [Related]
40. Extracorporeal Membrane Oxygenation Support for Cardiac Dysfunction Due to Kawasaki Disease Shock Syndrome.
Zhang H; Xie L; Xiao T
Front Pediatr; 2019; 7():221. PubMed ID: 31245335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
